APPLICATIONS

Enabling Innovation Through Advanced Linker Chemistry

Synthenera provides functionalized PEG linkers and related linker technologies for bioconjugation, targeted therapeutics, molecular labeling, and drug discovery.

ADC Development

Advanced Linker Technologies for Antibody–Drug Conjugates

High-performance linker chemistry is essential for the efficacy, stability, and safety of antibody–drug conjugates (ADCs). Synthenera provides monodisperse PEG linkers and functional linker building blocks that support efficient payload conjugation, optimized pharmacokinetics, and controlled drug release. Our portfolio includes both ready-to-ship catalog products and customized linker solutions to accelerate ADC discovery and preclinical development.

Monodisperse PEG Linkers

Cleavable & Non-Cleavable Designs

Payload Conjugation Strategies

Bioconjugation & Protein Modification

Precision Linkers for Protein Engineering and Bioconjugation

Protein conjugation requires highly selective chemistry and consistent molecular performance. Synthenera offers a comprehensive range of PEG linkers with reactive functional groups for efficient coupling of antibodies, proteins, peptides, enzymes, and other biomolecules. Our linker technologies improve conjugation efficiency while maintaining biological activity and structural integrity.

Selective Functional Groups

Enhanced Solubility

High Batch Consistency

Click Chemistry & Molecular Labeling

Bioorthogonal Linkers for Click Chemistry Applications

Click chemistry has become one of the most powerful tools in modern chemical biology. Our click chemistry PEG linkers provide rapid, selective, and bioorthogonal conjugation for molecular labeling, imaging, diagnostics, and biomolecule functionalization. With an extensive portfolio of click handles and customizable linker designs, Synthenera supports a broad spectrum of research applications.

Bioorthogonal Reactions

Diverse Click Handles

Ready-to-Ship Inventory

Drug Delivery & Targeted Protein Degradation

Linker Solutions for Emerging Therapeutic Platforms

Advanced linker technologies support emerging approaches in drug delivery and targeted protein degradation. Synthenera provides structurally diverse PEG-based linkers for PEGylated delivery systems, PROTAC research, and related therapeutic applications. Our broad linker portfolio offers flexibility for optimizing molecular design and conjugation strategies.

PEG-based Linker Solutions

PROTAC Research

Targeted Delivery